Performance of hospital companies to remain strong in Q3 of FY22, says ICRA
With most patients reporting mild infections on account of Omicron, pent-up demand and market share gains for organised players in the high-end and complex surgery space supported healthy occupancy levels for the sample set, ICRA said.
Two-wheeler demand remains weak compared with last year: ICRA
Automobile dealership industry has been witnessing several headwinds in the recent past, including subdued demand for two-wheelers (2W), supply constraints impacting growth of passenger vehicle (PV) sales, and high base effect limiting the growth in tractors segment. ICRA LTD. - 532835 - Board to consider FY22 results & Dividend on May 12, 2022
ICRA Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 12, 2022, inter alia, to consider and approve the audited financial results (standalone & consolidated) of the Company for the quarter and year ended March 31, 2022 and to recommend dividend, if any, on the equity shares of the Company for the financial year 2021-22. ICRA LTD. - 532835 - Board Meeting Intimation for Intimation Of Board Meeting
ICRA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please be informed that a meeting of the Board of Directors of ICRA Limited (the 'Company') is scheduled to be held on Thursday, May 12, 2022, inter alia, to consider and approve the audited financial results (standalone & consolidated) of the Company for the quarter and year ended March 31, 2022 and to recommend dividend, if any, on the equity shares of the Company for the financial year 2021-22. ICRA LTD. - 532835 - Certificate Pursuant To Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Please find enclosed a certificate for the financial year ended March 31, 2022, in compliance with Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Domestic air passenger traffic up 59% in FY22: ICRA
However, it is still about 40 per cent lower as compared to the pre-pandemic level, the credit ratings agency said.
Domestic pharma industry revenues projected to grow 6-8% in FY23: ICRA
The revenues of homegrown drug firms are expected to moderate from a growth of 8-10 per cent in 2021-22, it stated citing findings from the sample set of sample set of 21 companies. India may add 48,000 charging stations with 14,000 crore investment in 3-4 years: ICRA
ICRA expects a healthy electric vehicle penetration over the next five years
Bank Credit Growth May Touch 10% In Current Fiscal, Says ICRA
The outlook for banks is expected to be stable amid improvement in credit growth of 8.9-10.2 per cent and decline in provisions in the current fiscal ICRA LTD. - 532835 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed a disclosure in compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2022. You are requested to take the above on record.